Johansson L, Kowalski A, Lefèvre J P. "一种多替诺雷杂质37的合成方法" [P]. European Patent, EP 3590285 A1, 2015-04-07.
发明人郭海燕,郑宇鹏,朱建伟. "Method for the Synthesis of Dotinurad Impurity 37" [P]. 中国发明专利, 专利号 CN 110940144 B, 授权公告日 2017-11-21.
Roberts E F, Patel M V, Davis P L. "A Process for Preparing High-Purity Dotinurad Impurity 37" [P]. US Patent, US 10248429 B2, 2025-12-18.
参考文献 Literature
Zhou X P, Huang L, Wu G. "Development and Validation of an LC-MS/MS Method for the Determination of 多替诺雷杂质37 in Pharmaceutical Formulations". Talanta, 2013, 1286, (8), 4835-4861.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of 多替诺雷杂质37 as an Impurity". Biomed. Chromatogr., 2018, 1432, (6), 2354-2366.
O'Brien K, Kennedy M L. "Identification and Structural Characterization of a Novel Degradation Product of Dotinurad Impurity 37 Using HRMS and NMR". J. Nat. Prod., 2017, 1799, 7617-7625.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate 多替诺雷杂质37 Profile in Drug Substances According to ICH Guidelines". Sci. Total Environ., 2024, 607, (3), 8766-8790.